- ANAB +0.17%
Industry Analysts Just Upgraded Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts By 16%
Yahoo Finance · 3 weeks ago
Open | 23.43 |
High | 23.94 |
Low | 22.94 |
Mkt Cap | 646.08M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 23.61 |
52 Wk. Low | 13.36 |
52 Wk. High | 27.50 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 7.18M | 422.50% ▲ |
Net Income | -43.94M | - |
Diluted EPS | -1.64 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.89 | - |
Q1 2024 | -$1.57 | -$1.64 |
Q4 2023 | -$1.60 | -$1.59 |
S&P FuturesES=F | 5,386.25+2.25 (+0.04%) |
Dow FuturesYM=F | 38,801.00+7.00 (+0.02%) |
Nasdaq FuturesNQ=F | 19,256.50+14.25 (+0.07%) |
123.88-0.50% | |
Apple Inc.AAPL | 207.15+7.26% |
33.80+11.04% |